Warmly Congratulate Henan Shuguang Jianshi Group 2012 Sincere Appreciation Friendship Conference Held

Release time:

2018-08-08

Together Don't leave, don't abandon Dawn Swordman Always have you

Shuguang Jianshi Group held a grand ceremony2012Sincere Appreciation Meeting

Dawn is more wonderful with you, and chivalrous athletes will always be brilliant-on the morning of January 6, 2013, dawning chivalrous group's 2012 sincere appreciation and friendship conference was solemnly held in Sheraton hotel. The group spent nearly one million, awarded the sales elite, nearly 500 merchants from all over the country gathered together to share the feast.

In 2012, under the leadership of Chairman Wan Zhiyong, Shuguang Jianshi Group developed scientifically and forged ahead, and achieved a bumper harvest of both economic and social benefits. The further expansion of production scale, the substantial increase in sales revenue, the steady improvement of product quality, the frequent emergence of bright spots in scientific and technological innovation, the sound and color of corporate culture, and the significant improvement of staff treatment have won unanimous praise from all walks of life. it has laid a solid foundation for the listing of enterprises. In 2012, the group's sales revenue increased by more than 50%, and the total output of the infusion set series and syringe series was nearly 1 billion, making a historic breakthrough.

Wan Zhihong, general manager of Shuguang Jianshi Group, said with confidence that in 2013, the group will still adhere to the principle of quality first, further optimize product structure and increase production capacity. A large number of new products will be launched. Precision infusion sets, indwelling needles, self-exhausting and self-stopping infusion sets, infusion pumps, anesthesia packs, automatic biochemical analyzers, biochemical reagents, etc. will all enter mass production. These new products will become the group's new profit growth point,Shuguang Jianshi Group will stride forward towards the national first-class medical device production base.